|
|
|
|
| Vasogen Inc. - New Approaches to Treating Chronic Inflammation | |
|
April 25, 2008
April 14, 2008
  Vasogen's products in development target destructive chronic inflammation. Vasogen's lead product, the Celacade™ technology, has received European regulatory approval under the CE Mark for the treatment of chronic heart failure.  |
